Clinical Trial Update: Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis [NA]

View source ↗

Summary

A clinical trial evaluating the effect of Saccharomyces cerevisiae as an adjunct to standard therapy for vulvovaginal candidiasis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• Saccharomyces cerevisiae (Saccharomyces cerevisiae)

Snippet

Sponsor: Lesaffre International | Conditions: Vulvo-vaginal Candidiasis | NA | Status: TERMINATED